Seroprevalence of varicella zoster virus among pregnant women in Hong Kong: Comparison with self-reported history

Vaccine

Volumn 29, Issue 46, 2011, Pages 8186-8188

  Fung, Linda Wen Ying ^a   Lao, Terence T ^a   Suen, Stephen Sik Hung ^a   Chan, Oi Ka ^a   Lau, Tze Kin ^a   Ngai, Karry L K ^a   Chan, Paul Kay Sheung ^a   Leung, Tak Yeung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chickenpox; Pregnancy; Vaccination; Varicella

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HERPES ZOSTER; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SELF REPORT; SEROPREVALENCE; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS IMMUNITY;

ADULT; ANTIBODIES, VIRAL; CHICKENPOX; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRUS 3, HUMAN; HONG KONG; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANT WOMEN; SEROEPIDEMIOLOGIC STUDIES;

EID: 80053961025     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.090     Document Type: Article

References (14)

1. Byrne BMP, Crowley PA, Carrington D. Chickenpox in pregnancy. Royal College of Obstetricians and Gynaecologists Green-top Guideline No. 13; 2007.
2. Sauerbrei A., Wutzler P. Herpes simplex and varicella zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: varicella-zoster virus infections. Med Microbiol Immunol 2007, 196(2):95-102.
3. Harger J.H., Ernest J.M., Thurnau G.R., Moawad A., Momirova V., Landon M.B., et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Disease 2002, 185(4):422-427.
4. Marin M., Güris D., Chaves S.S., Schmid S., Seward J.F. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-4):1-40. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC).
5. Centre of Health Protection, Department of Health, Hong Kong SAR. Statistics on communicable diseases. [accessed 28.03.2011]. http://www.chp.gov.hk/.
6. Wagenpfeil S., Neiss A., Banz K., Wutzler P. Empirical data on the varicella situation in Germany for vaccination decisions. Clin Microbiol Infect 2004, 10(5):425-430.
7. Sinha D.P. Chickenpox-a disease predominantly affecting adults in rural West Bengal, India. Int J Epidemiol 1976, 5(4):367-374.
8. Garnett G.P., Cox M.J., Bundy D.A., Didier J.M., St Catharine J. The age of infection with varicella-zoster virus in St. Lucia, West Indies. Epidemiol Infect 1993, 110(2):361-372.
9. Fairley C.K., Miller E. Varicella-zoster virus epidemiology-a changing scene?. J Infect Dis 1996, 174(Suppl 3):S314-S319.
10. Pourahmad M., Davami M.H., Jahromi A.R. Evaluation of anti-varicella antibody in young women before their marriage: a sero-epidemiologic study in Iran. J Clin Virol 2010, 48(4):260-263.
11. Talukder Y.S., Kafatos G., Pinot de Moira A., Aquilina J., Parker S.P., Crowcroft N.S., et al. The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK. Epidemiol Infect 2007, 135(8):1344-1353.
12. Varicella Active Surveillance Project, Centre of Disease Control and Prevention (CDC). [accessed 28.03.2011]. http://www.cdc.gov/vaccines/stats-surv/vasp/default.htm%23results.
13. Nardone A., Tischer A., Andrews N., Backhouse J., Theeten H., Gatcheva N., et al. Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 2008, 86:118-125.
14. Pebody R.G., Edmunds W.J., Conyn-van Spaendonck M., Olin P., Berbers G., Rebiere I., et al. The seroepidemiology of rubella in Western Europe. Epidemiol Infect 2000, 125:347-357.